Skip to content

Cancer Health Center

Font Size

Newcastle Disease Virus (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - Human / Clinical Studies

Table 3. Studies of NDV-Infected Tumor Cell Vaccines in Which Therapeutic Benefit Was Assesseda

Reference Citation(s)Type of StudyType of CancerNo. of Patients: Enrolled; Treated; ControlbStrongest Benefit ReportedcConcurrent TherapydLevel of Evidence Scoree
No. = number; wk = week.
a See text and theNCI Dictionary of Cancer Termsfor additional information and definition of terms.
b Number of patients treated plus number of patients control may not equal number of patients enrolled; number of patients enrolled = number of patients initially recruited/considered by the researchers who conducted a study; number of patients treated = number of enrolled patients who were given the treatment being studiedAND for whom results were reported; historical control subjects are not included in number of patients enrolled.
c The strongest evidence reported that the treatment under study has anticancer activity or otherwise improves the well-being of cancer patients.
d Chemotherapy, radiation therapy, hormonal therapy, or cytokine therapy given/allowed at the same time as vaccine therapy.
e For information about levels of evidence analysis and an explanation of the level of evidence scores, seeLevels of Evidence for Human Studies of Cancer Complementary and Alternative Medicine.
f Only 48 patients were treated with NDV-infected tumor cell vaccines; the remaining patients were treated with another type of vaccine.
g The patients were divided into groups that received a high-quality vaccine or a low-quality vaccine; the low-quality vaccine groups served as the controls; 32, 13, and 18 patients with early breast cancer, metastatic breast cancer, and metastatic ovarian cancer, respectively, received high-quality vaccines; the corresponding low-quality vaccine groups contained 31,14, and 13 patients.
h There were 39 evaluable patients in this study, but findings were reported for only 24 patients.
i Article does not provide enough information.
[32]Phase II/III (adjuvant setting)Melanoma29; 21; 8No advantage of vaccine for disease free survival or overall survivalNone1iA
[29]Phase III (adjuvant setting)Colorectal with liver metastases51; 25; 26Planned subgroup analysis, overall and disease free survival advantages in the colon of cancer patientsProtocol therapy was given after complete surgical resection of primary tumor and liver metastases1iiA
[31]Phase IIGlioblastoma35; 23; 87 (concurrent controls identified from within same hospital)Median progression-free survival of vaccinated patients was 40 wk (vs. 26 wk in controls; log-rank test,P = .024), median OS of vaccinated patients was 100 wk (vs. 49 wk in controls; log-rank test,P< .001)Protocol therapy after surgical debulking of tumor followed by radiation therapy2A
[15,22]Phase II trialMetastatic colorectal23; 23; Historical controlsImproved disease-free survivalNo3iiA
[23]Phase II trialOvarian82; 24h; NoneImproved disease-free survivalYes3iiDi
[16]Phase II trialAdvanced colorectal57; 48f; Historical controlsImproved overall survivalNo3iiiA
[17]Retrospective analysisEarly breast63; 63; Internal controlsgImproved overall survivalYes3iiiA
[21]Phase II trialMetastatic renal cell40; 40; Historical controlsImproved overall survival, 11 patients with complete/partial responsesYes3iiiA
[19]Phase II trialVarious advanced43; 31; NoneComplete tumor response, 1 patientYes3iiiDiii
[33]Phase IIGastrointestinal tumors, stage IV25; 25; 01 Complete response, 5 partial responses, overall response rate = 24%None described3iiiDiii
[33]Phase IIIColorectal567; 310; 257Higher mean and median survival for vaccination group compared to the resection group aloneNone describedNone describedi
1|2|3|4|5|6|7|8|9|10|11|12|13

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Colorectal cancer cells
A common one in both men and women.
Lung cancer xray
See it in pictures, plus read the facts.
 
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Do you know the symptoms?
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article